A New Clinical...

June 3, 2010 — A new clinical trial comparing pallidal and subthalamic neurostimulation in Parkinson's disease has found both approaches are acceptable. The subthalamic nucleus is the target of choice for most surgeons, but these new numbers confirm there is another option.